These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7717849

  • 21. Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney.
    Richter E, Friesenegger S, Engl J, Tricker AR.
    Toxicology; 2000 Apr 03; 144(1-3):83-91. PubMed ID: 10781874
    [Abstract] [Full Text] [Related]

  • 22. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS.
    Chem Res Toxicol; 2007 Feb 03; 20(2):235-45. PubMed ID: 17305407
    [Abstract] [Full Text] [Related]

  • 23. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG, Akerkar SA, Richie JP, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep 03; 4(6):635-42. PubMed ID: 8547830
    [Abstract] [Full Text] [Related]

  • 24. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
    Staretz ME, Murphy SE, Patten CJ, Nunes MG, Koehl W, Amin S, Koenig LA, Guengerich FP, Hecht SS.
    Drug Metab Dispos; 1997 Feb 03; 25(2):154-62. PubMed ID: 9029045
    [Abstract] [Full Text] [Related]

  • 25. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
    Balbo S, Johnson CS, Kovi RC, James-Yi SA, O'Sullivan MG, Wang M, Le CT, Khariwala SS, Upadhyaya P, Hecht SS.
    Carcinogenesis; 2014 Dec 03; 35(12):2798-806. PubMed ID: 25269804
    [Abstract] [Full Text] [Related]

  • 26. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
    Richie JP, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 03; 6(10):783-90. PubMed ID: 9332760
    [Abstract] [Full Text] [Related]

  • 27. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.
    Schrader E, Hirsch-Ernst KI, Richter E, Foth H.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 03; 357(3):336-43. PubMed ID: 9550307
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cotinine effects on bile flow and biliary NNK elimination.
    Meiser H, Atawodi SE, Richter E.
    Eur J Med Res; 2000 Jun 20; 5(6):241-6. PubMed ID: 10882639
    [Abstract] [Full Text] [Related]

  • 34. Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in rhesus monkeys.
    Meger M, Richter E, Zwickenpflug W, Oehlmann C, Hargaden MB, A-Rahim YI, Vesell ES.
    Drug Metab Dispos; 1999 Apr 20; 27(4):471-8. PubMed ID: 10101142
    [Abstract] [Full Text] [Related]

  • 35. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP.
    Cancer; 2005 Apr 01; 103(7):1420-6. PubMed ID: 15726545
    [Abstract] [Full Text] [Related]

  • 36. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.
    Hecht SS, Chung FL, Richie JP, Akerkar SA, Borukhova A, Skowronski L, Carmella SG.
    Cancer Epidemiol Biomarkers Prev; 1995 Dec 01; 4(8):877-84. PubMed ID: 8634661
    [Abstract] [Full Text] [Related]

  • 37. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N, Hecht SS.
    Chem Res Toxicol; 1999 Feb 01; 12(2):164-71. PubMed ID: 10027794
    [Abstract] [Full Text] [Related]

  • 38. Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products.
    Kovi RC, Johnson CS, Balbo S, Hecht SS, O'Sullivan MG.
    Toxicol Pathol; 2018 Feb 01; 46(2):184-192. PubMed ID: 29390940
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 01; 5(7):521-5. PubMed ID: 8827356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.